SANUWAVE Health and JV Partner Diversa S.A. Announce Distribution Agreement with Grupo Suprimed

Rhea-AI Summary

SANUWAVE Health, Inc. (OTCQB:SNWV) has announced a distribution agreement with Grupo Suprimed to market and sell its dermaPACE System in Brazil's private healthcare sector. This agreement aims to strengthen SANUWAVE's presence in Brazil, the largest healthcare market in Latin America, which has a vast network of hospitals and healthcare professionals. SANUWAVE’s CEO highlighted the potential for improving healthcare quality and lowering costs through this partnership, while Grupo Suprimed is recognized as a significant distributor of medical products in the region.

Positive

• Establishing a distribution agreement with Grupo Suprimed enhances commercial footprint in Brazil, a major healthcare market.
• The dermaPACE System is already licensed for advanced wound care in Brazil, indicating regulatory compliance and market readiness.
• Collaboration with Grupo Suprimed, a leading medical product distributor, may facilitate efficient product penetration in the Brazilian market.

Negative

• None.

SUWANEE, GA / ACCESSWIRE / May 21, 2021 / SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation wound care products and its JV partner Diversa S.A. have announced a new distribution agreement with Grupo Suprimed to market and sell the dermaPACE^® System in the private healthcare market in Brazil. The dermaPACE^® System is currently licensed or approved for advanced wound care indications in Brazil, Mexico and dozens of countries around the world.

Kevin Richardson, Chairman and Chief Executive Officer of SANUWAVE said, "Brazil represents the largest healthcare market in Latin America and one of the largest healthcare markets in the world. With approximately 6,400 hospitals and 432,000 doctors, Brazil is an ideal market to bring quality products and clinical services that improve healthcare and lower costs. This agreement helps broaden the SANUWAVE commercial footprint and expands our Energy First platform."

Grupo Suprimed is one of the largest distributors of surgical, medical and hospital products in Brazil.

Adilson Magri, Chief Executive Officer of Grupo Suprimed´s said, "The success and sustainability of a business in the medical field depends on improved quality of life for patients and functionality for healthcare professionals. With this goal in mind, our distribution portfolio brings innovative, high-tech and efficient solutions to the healthcare market."

Daniel Ferreira, Chief Executive Officer of Diversa, S.A. commented, "Our JV partnership with SANUWAVE allows us to bring the transformative dermaPACE System therapy to the Brazilian market to improve the outcomes for chronic wounds in an efficient, cost-effective manner. Our shared values and focus on the well-being of diabetic patients was an important factor in Grupo Suprimed's choice to use Diversa as a distribution partner."

"Our agreement will help expand sales in Sao Paulo city and other regions in Brazil, including Valinhos-SP, São Paulo-SP, Ribeirão Preto-SP, Porto Alegre-RS, Manaus -AM and Macapá-AP. Suprimed is one of the most respected medical device distributors in Brazil."

About Diversa S.A.

Diversa S.A. is a Joint Venture in Brazil between SANUWAVE Health Inc. and the company's CEO, Daniel Feliciano Ferreira. Diversa S.A. is a company that looks both for the value generated to shareholders and society.

About the Suprimed Group

The Suprimed Group is one of the largest distributors of surgical, medical and hospital products in Brazil. Suprimed was established 25 years ago and currently employs more than 250 employees across four branch offices in Brazil.

About SANUWAVE Health

SANUWAVE Health (OTCQB: SNWV) is focused on the research, development, and commercialization of its patented, Energy First non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.

SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body's normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, plastic/cosmetic and cardiac/endovascular conditions. For more information, please visit. www.SANUWAVE.com.

Investor Relations Contact
Brian M. Prenoveau, CFA
Managing Director
MZ Group - MZ North America
(561) 489-5315
SNWV@mzgroup.us
www.mzgroup.us

SOURCE: SANUWAVE Health, Inc.

View source version on accesswire.com:
https://www.accesswire.com/648512/SANUWAVE-Health-and-JV-Partner-Diversa-SA-Announce-Distribution-Agreement-with-Grupo-Suprimed

FAQ

What is the significance of SANUWAVE's distribution agreement with Grupo Suprimed?

The distribution agreement allows SANUWAVE to expand its market presence in Brazil, leveraging Grupo Suprimed's established distribution network.

When was the distribution agreement between SANUWAVE and Grupo Suprimed announced?

The agreement was announced on May 21, 2021.

What product will SANUWAVE distribute in Brazil through Grupo Suprimed?

SANUWAVE will distribute its dermaPACE System for advanced wound care in Brazil.

What market does the dermaPACE System serve?

The dermaPACE System serves the advanced wound care market, currently approved in Brazil and other countries.

What opportunity does Brazil represent for SANUWAVE?

Brazil represents the largest healthcare market in Latin America, providing significant growth potential for SANUWAVE's products.